[1] | Sepkowitz K.A. AIDS- the first 20 years. New England Journal of Medicine, 2001, 344(23), 1764-1772. |
|
[2] | Del, R., J. Cand and Curran, W Epidemiology and prevention of acquired immunodeficiency syndrome and Human immunodeficiency virus infection. In Principles and Practice of Infectious Diseases. 7th ed. Eds., Mandell G.L., Douglas, R., D. and Bennett J., E. Churchill Livinstone Elsevier. Philadelphia, 2010, Volume1 pp: 1635-1661. |
|
[3] | Holmes C.B., Losina E., Walensky, R.P., Yazdanpanah Y., Freedberg K.A. Review of Human Immunodeficiency Virus Type-1 Related opportunistic infections in sub-saharan Africa. Journal of Clinical Infectious Diseases, 2003, 36(5), 656-662. |
|
[4] | Alter, M. Epidemiology of viral hepatitis and HIV co-infection. Journal of Hepatology, 2006, 44(1), 6-9. |
|
[5] | Chun H.M., Roediger M.P., Huppler K.H., Thio C.L., Agan B.K., Bradley W.P., Peel S.A., Jagodzinski L.L., Weintrob A.C., Ganesan, A., Crum-Cianflone N.F., Maguire J.D., Landrum M.L. Hepatitis B virus co-infection Negatively impacts on HIV outcomes in seroconverters. Journal of Infectious Diseases, online edition, 2011. |
|
[6] | Center for Disease Control and Prevention (CDC). (2011). Updated U.S public health service guidelines for the management of occupational exposure to HBV, HCV and HIV and recommendation for post exposure prophylaxis. CDC MMWR, 2011, 50(RR-11):1-42. |
|
[7] | WHO. Hepatitis B factsheet. World Health Organisation, Geneva, Switzerland, 2012, Available from http://www.who.int/mediacentre/factsheet/fs204/en/ retrieved 27/02/2013. |
|
[8] | Burnett R.J., Francois G., Kew M.C., Leroux-Roels, G., Mehause, A., Hoosen, A. A and Mphahlele, M. J. Hepatitis B virus and Human immunodeficiency virus co-infection in sub-Saharan Africa: a call for further investigation. Liver International, 2005, 25, 201-213. |
|
[9] | Bodsworth N.J., Cooper D.A., Donovan B. The influence of human immunodeficiency virus type-1 infection on the development of the hepatitis B virus carrier state. Journal of Infectious Diseases, 1991, 163, 1138-1139. |
|
[10] | Vento S. Di Parri G., Garofano T., Concia E., Basseti D. Reactivation of Hepatitis B in AIDS. Lancet, 1989, 2, 108-109. |
|
[11] | Rodriguez-Mendez M.L., Gonzalez-Quintela A. and Aguilera A. Prevalence, patterns and course of past hepatitis B virus infection in intravenous drug users in HIV-1 infection. American Journal of Gastroenterology, 2000, 95(5), 1316-1322. |
|
[12] | Scharschmidt B.F., Held M.J., Hollander H.H. Hepatitis B in patients with HIV infection: relationship to AIDS and patient survival. Annals of Internal Medicine, 1992, 117(10), 837-838. |
|
[13] | Piroth L., Sene D., and Pol S. Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV infected patients. AIDS, 2007, 21(10), 13323-1331. |
|
[14] | Uneke C.J., Ogbu P.U.I., Anyanwu G.I., Njoku M.O and Idoko J.H. Prevalence of Hepatitis B surface antigen among blood donors and HIV infected patients in Jos, Nigeria. Memorias do Instituto Oswaldo cruz Cruz Rio de Janerio, 2005, 100(1), 13-16. |
|
[15] | Eaton D.K., Kann L., KinchenS., Shanklin S., Ross J., Hawkins J., Harris W.A., Lowry R., McManus T., Chyen D., Lim C., Brener N.D., Wechsler, H. Youth risk behavior surveillance- United States, 2007. MMWR Surveillance Summaries, 2008, 57(4), 1-131. |
|
[16] | Mayaphi S.H., Rossow T.M., Masemola D.P., Olorunju S.A.S., Mphahlele M.J. HBV/HIV co-infection: the dynamics of HBV in South African patients with AIDS. South African Medical Journal, 2012, 102(3), 157-162. |
|
[17] | Taura D.W., Oyeyi T.T. and Hafsat M.N. Prevalence of Hepatitis B surface antigen (HBsAg) among HIV positive patients attending Aminu Kano Teaching Hospital, Kano, Nigeria. International Journal of Biomedical and Health Sciences, 2008, 4(1), 33-39. |
|